首页> 外文期刊>Hormone and Metabolic Research >Changes in acyl ghrelin, des-acyl ghrelin, and ratio of acyl ghrelin to total ghrelin with short-term refeeding in female inpatients with restricting-type anorexia nervosa.
【24h】

Changes in acyl ghrelin, des-acyl ghrelin, and ratio of acyl ghrelin to total ghrelin with short-term refeeding in female inpatients with restricting-type anorexia nervosa.

机译:患有限制型神经性厌食症女性住院者的短期补充喂养时,酸性生长素释放肽,去酰基生长素释放肽和酰基生长素释放肽与总生长素释放肽的比率发生变化。

获取原文
获取原文并翻译 | 示例
           

摘要

Restricting type of anorexia nervosa (AN-R) is a serious disorder affecting adolescents and young adults and decreases quality of life over a long period. Successful weight restoration is an important prognostic factor for disease outcome; however, the underlying mechanism of refeeding resistance, a core psychopathology relevant to 'ambivalent' eating behaviors, remains unclear in this disorder. Ghrelin plays an important role in the regulation of growth hormone release, appetite, and energy metabolism. However, the early progress of these patients and changes in the levels of acyl ghrelin and des-acyl ghrelin during treatment were not reported. The purpose of this study was to determine the changes in ghrelin levels (acyl and des-acyl) during early treatment. As a result, des-acyl ghrelin in AN-R patients is higher than in control subjects before the therapy, but it decreases with treatment. The plasma des-acyl ghrelin level in AN-R patients started decreasing more rapidly and in early stage of the hospitalization than ever reported, and after 8 weeks, it is significantly lower than in control subjects. It means that des-acyl ghrelin is sensitive and changeable with their nutrition state. Furthermore, the ratio of the acyl ghrelin to total ghrelin increases with 8 weeks treatment. Eight weeks after, energy intake of the AN-R patients is recovered near the normal range with a daily energy intake of 1 700+/-93.54 kcal. These findings may be valuable for future AN-R treatments in order to increase acyl ghrelin and decrease des-acyl ghrelin, thereby influencing the refeeding outcome.
机译:限制型神经性厌食症(AN-R)是一种严重的疾病,会影响青少年和年轻人,并长期降低生活质量。成功的体重恢复是疾病预后的重要预后因素。然而,在这种疾病中,尚不清楚与“矛盾”进食行为有关的核心精神病理学-再进食抵抗的潜在机制。 Ghrelin在调节生长激素释放,食欲和能量代谢中起重要作用。然而,没有报道这些患者的早期进展以及治疗期间酰基生长素释放肽和去酰基生长素释放肽水平的变化。这项研究的目的是确定早期治疗过程中生长素释放肽水平(酰基和去酰基)的变化。结果,AN-R患者中的去酰基生长素释放肽水平高于对照组,但随治疗而降低。在AN-R患者中,血浆去酰基生长素释放肽水平开始下降,并且在住院早期阶段比以往任何时候都报告的下降更快,并且在8周后,它显着低于对照组。这意味着去酰基饥饿素的营养状态敏感且易变。此外,酰基生长素释放肽与总生长素释放肽的比例随着治疗8周而增加。八周后,AN-R患者的能量摄入恢复到正常范围附近,每日能量摄入为1 700 +/- 93.54 kcal。这些发现对于将来的AN-R治疗可能是有价值的,以增加酰基生长素释放肽和降低脱酰基生长素释放肽,从而影响补料结果。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号